Neurologian yksikkö
Department of Neurology

Julkaisut 1993
Publications 1993

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Alhainen K et al. The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminocridine in patients with Alzheimer's disease.
2 Alhainen K et al. Psychometric discrimination of tetrahydroaminoacridine responders in Alzheimer patients.
3 Alhainen K, Riekkinen PJ. Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy.
4 Brankack J et al. Epileptogenic spikes and seizures but not high voltage spindles are induced by local frontal cortical application of gamma-hydroxybutyrate.
5 Castrén E et al. The induction of LTP increases BDNF and NGF mRNA but decreases NT-3 mRNA in the dentate gyrus.
6 Cochius Ji et al. Unverssicht-Lundborg disease: absence of nonallelic genetic heterogeneity.
7 Haapalinna A et al. Alfa-2-antagonistin vaikutus oppimis- ja muistitoimintoihin koe-eläimillä.
8 Halonen T et al. Elevated seizure threshold and impaired spatial learning in transgenic mice with putrescine overproduction in the brain.
9 Hartikainen P et al. Cognitive and memory deficits in untreated Parkinson's disease and amyotropic lateral sclerosis patients: a comparative study.
10 Heinonen O et al. Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome.
11 Helkala EL, Riekkinen P. Neuropsykologiset teoriat otsalohkojen toiminnasta.
12 Jolkkonen J et al. CSF corticotrophin-releasing factor is not affected in panic disorder.
13 Jäkälä P et al. The behavioral effects of serotonin synthesis inhibition and quisqualic acid induced lesions of the nucleus basalis magnocellularis in rats.
14 Jäkälä P et al. Effects of p-chlorophenylalanine and methysergide on the performance of a working memory task.
15 Jäkälä P et al. The effects of tacrine and zacopride on the performance of adult rats in the working memory task.
16 Koivisto K et al. Poststroke depression and rehabilitation outcome.
17 Koponen HJ, Riekkinen PJ. A prospective study of delirium in elderly patients admitted to a psychiatric hospital.
18 Kuikka JT et al. Initial experience with SPET examinations using iodine 123-labelled 2B-carbomethoxy-3B-(4-iodophenyl)tropane in human brain.
19 Kälviäinen R et al. Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies.
20 Kälviäinen R et al. Place of newer antiepileptic drugs in the treatment of epilepsy.
21 Lahtinen H. Hippocampus in experimental models of temporal lobe epilepsy - amino acid-mediated neurotransmission and nerve cell injury following the transection of fimbria-fornix and the electrical stimulation of perforant pathway in rat.
22 Lahtinen H et al. NMDA-sensitive (3H) glutamate binding in the epileptic rat hippocampus: an autoradiographic study.
23 Lahtinen H et al. Long-term alterations in NMDA-sensitive L-(3H) glutamate binding in the rat hippocampus following fimbria-fornix lesioning.
24 Lahtinen H et al. Biochemical and morphological changes in the rat hippocampus following transection of the fimbria-fornix.
25 Lahtinen H et al. Preservation of hippocampal NMDA receptors may be crucial for spatial learning after epileptic seizures in rats.
26 Laulumaa V et al. Imaging of D2 dopamine receptors of patients with Parkinson's disease using single photon emission computed tomography and iodobenzamide I-123.
27 Magloczky ZS, Freund TF. Selective neuronal death in the contralateral hippocampus following unilateral kainate injections into the CA3 subfield.
28 Mazurkiewicz M et al. Effects of single and repeated administration of vigabatrin on the performance of non-epileptic rats in a delayed non-matching to position task.
29 Mazurkiewicz M et al. Effects of an inhibitor of GABA-aminotransferase (gamma-vinyl GABA) on the spatial navigation deficit induced by nicotinic blockade.
30 Mervaala E et al. Electrophysiological and neuropsychological effects of a central alpha2-antagonist atipamezole in healthy volunteers.
31 Miettinen R. Inhibitory circuits and subcortical innervation of the rat hippocampus: implications for normal function and pathophysiological processes.
32 Miettinen R et al. Persisting axonal degeneration in the hippocampus after transection of the fimbria-fornix.
33 Miettinen R et al. Neocortical, hippocampal and septal parvalbumin- and somatostatin-containing neurons in young and aged rats: correlation with passive avoidance and water maze performance.
34 Pekkonen E et al. Mismatch negativity area and age-related auditory memory.
35 Pitkänen A, Amaral DG. Distribution of Cabindin-D28k immunoreactivity in the monkey temporal lobe: the amygdaloid complex.
36 Pitkänen A, Amaral DG. Distribution of parvalbumin-immunore-active cells and fibers in the monkey temporal lobe: the amygdaloid complex.
37 Pitkänen A, Amaral DG. Distribution of parvalbumin-immunore-active cells and fibers in the monkey temporal lobe: the hippocampal formation.
38 Pitkänen A et al. Long-term antiepileptic efficacy of Vigabatrin in drug-refactory epilepsy of mentally retarded epileptic patients: A 5-year follow-up.
39 Reeben M et al. Tissue-specific expression of rat light neurofilament promoter-driven reporter gene in transgenic mice.
40 Riekkinen M et al. Pharmacological consequences of nicotinergic plus serotonergic manipulations.
41 Riekkinen P Jr et al. The effects of alpha-2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats.
42 Riekkinen P Jr et al. Effects of muscarinic receptor agonists and anticholinesterase drugs on high voltage spindles and slow waves.
43 Riekkinen P Jr et al. Effects of nicotine on neocortical EEG activity in rats.
44 Riekkinen P Jr et al. Effects of ZK 93426 on muscarinic and nicotinic antagonist or nucleus basalis lesioning-unduced electrocortical slowing.
45 Riekkinen P Jr et al. Alpha-1-adrenoceptor antagonist decreases alpha-2-adrenoceptor antagonist-induced high voltage spindle suppression in adult and aged rats.
46 Sarti C et al. Geographic variation in the incidence of non-fatal stroke in Finland. Are the observed differences real?
47 Sarti C et al. Stroke mortality and case-fatality rates in three geographic areas of Finland from 1983 to 1986.
48 Sirviö J et al. Dose- and parameter-dependent effects of atipamezole, an alpha-2-antagonist, on the performance of rats in a five-choice serial reaction time task.
49 Sivenius J et al. Vigabatrin (gamma-vinyl-GABA): Neuropathologic evaluation in five patients.
50 Sivenius J et al. European Stroke Prevention Study (ESPS): Antithrombotic therapy is also effective in the elderly.
51 Sivenius J et al. Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event.
52 Soininen H et al. Circulating immune complexes in sera from patients with Alzheimer's disease, subjects with age-associated memory impairment.
53 Soininen H et al. Age-related cognitive decline and electroencephalogram slowing in Down's syndrome as a model of Alzheimer's disease.
54 Soininen H et al. Wide third ventricle correlates with low choline acetyltransferase activity of the neocortex in Alzheimer patients.
55 Soininen H, Riekkinen P. Tarkkaavaisuuden säätely.
56 Yavich L et al. The interaction of L-deprenyl and scopolamine on spatial learning/memory in rats.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008